PET imaging probe for EGFR mutation lung cancer
Part of Cancer clinical trials.
This trial is testing a new imaging probe that binds to EGFR mutations, which are common in some lung cancers. If you have lung cancer with a confirmed EGFR mutation, this scan may help doctors see your cancer more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have lung cancer that is measurable on scans
- Your doctor expects you to live more than 3 months
- You have good liver and kidney function
- You agree to use effective birth control (if applicable) during the study and for 6 months after
- You can lie still for a PET/CT scan and do not have severe claustrophobia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.
This trial tests a new radioactive imaging agent that helps doctors see EGFR-positive lung cancer cells. It is for people with advanced non-small cell lung cancer that has an EGFR mutation, and who are not currently on a changing cancer treatment.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This trial is testing a new radioactive imaging agent that targets a protein called Nectin-4, which is often found on lung tumors. The scan will help doctors see if the tumor is visible and how it spreads, which may guide better treatment decisions for lung cancer patients.
This trial uses a special radioactive probe to find gastric cancer cells during imaging. It may help doctors see tumors more clearly and catch the disease earlier.
This trial tests a new type of imaging scan that uses a special tracer to help doctors see solid tumors more clearly. The scan may help improve how tumors are detected and monitored during treatment.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.